CorMedix Inc. — Director's Dealing 2010

Apr 1, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CorMedix Inc. (CRMD)
CIK: 0001410098
Period of Report: 2010-03-30

Reporting Person: Pfaffle Antony (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-03-30	Common Stock, $0.001 par value per share	C	12375	—	Acquired	14850	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-03-30	Non-Voting Subordinated Class A Common Stock	$	C	12375	Disposed		Common Stock, $0.001 par value (12375)	Direct
2010-03-30	Stock option (right to buy)	$3.1250	A	20000	Acquired	2020-03-30	Common Stock, $0.001 par value (20000)	Direct

Footnotes

F1: All shares of Non-Voting Common Stock automatically converted into shares of common stock at a conversion ratio of one share of common stock for 7.836 shares of
Non-Voting Common Stock upon the closing of the Company's initial public offering on March 30, 2010.

F2: These options vest as follows: 1/3 on March 30, 2010; an additional 1/3 on March 30, 2011; and the remaining 1/3 on March 30, 2012.